License and Collaboration Agreements - MD Anderson Cancer Center (Details) - University Of Texas M D Anderson Cancer Center - USD ($) $ in Millions		3 Months Ended
Oct. 06, 2020	Mar. 31, 2026	Mar. 31, 2025
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Collaboration agreement, term (in years)	5 years
Committed funding	$ 15.0
Committed funding remaining		$ 6.0
Collaboration costs		$ 0.1	$ 0.4

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 730
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483041/730-20-50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 730
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483041/730-20-50-1

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration